Breaking News, Collaborations & Alliances

eXmoor Pharma, Royal Free London Join Forces to Strengthen UK CGT Manufacturing Pathway

Collaboration aims to create a joined-up translational pathway that reduces complexity, accelerates timelines, and strengthens the UK’s position in advanced therapeutics.

Author Image

By: Charlie Sternberg

Associate Editor

eXmoor Pharma, an integrated cell and gene therapy CDMO, and Royal Free London NHS Foundation Trust, through its Cell and Vector Innovation Centre (CVIC), have entered a strategic collaboration to build a seamless, scalable pathway for cell and gene therapy development and manufacturing in the UK. The collaboration brings together CVIC’s early-phase clinical manufacturing expertise with eXmoor’s later-phase clinical manufacturing capabilities and its planned progression toward a commerc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters